Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Appl Opt ; 63(16): 4366-4371, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38856615

ABSTRACT

We present the retrieval of depth-resolved temperature measurements in water using Raman LiDAR. Using a 5 m pipe of laboratory water, we recover non-homogeneous temperature profiles with a temperature accuracy ranging between 0.35°C and 0.85°C, and a position resolution of 28 cm.

2.
Opt Express ; 25(3): 2840-2851, 2017 Feb 06.
Article in English | MEDLINE | ID: mdl-29519001

ABSTRACT

Raman spectra for a natural water sample have been comprehensively investigated as a function of temperature and salinity, and we demonstrate that temperature and salinity can be determined from Raman spectra with RMS errors consistently below ±0.2 °C and ±0.6 PSU respectively where there is variation only in one parameter. Most significantly, we have applied multivariate methods to show that both temperature and salinity can be determined simultaneously from Raman spectra with RMS errors of ±0.7 °C and ±1.4 PSU respectively, and designed a three-channel Raman spectrometer that will be used for future studies.

3.
Opt Express ; 23(25): 31844-56, 2015 Dec 14.
Article in English | MEDLINE | ID: mdl-26698976

ABSTRACT

A detailed investigation into the use of Raman spectroscopy for determining water temperature is presented. The temperature dependence of unpolarized Raman spectra is evaluated numerically, and methods based on linear regression are used to determine the accuracy with which temperature can be obtained from Raman spectra. These methods were also used to inform the design and predict the performance of a two-channel Raman spectrometer, which can predict the temperature of mains supply water to an accuracy of ± 0.5 °C.

4.
Opt Express ; 16(26): 21958-63, 2008 Dec 22.
Article in English | MEDLINE | ID: mdl-19104630

ABSTRACT

Efficient multi-Watt continuous-wave (CW) yellow emission at 586.5 nm is demonstrated through intracavity frequency-doubling of a Nd:GdVO(4) self-Raman laser pumped at 880 nm. 2.51 W of CW yellow emission with an overall diode-to-yellow conversion efficiency of 12.2% is achieved through the use of a 20 mm long Nd:GdVO(4) self-Raman crystal and an intracavity mirror which facilitates collection of yellow emission generated within the resonator, and reduces thermal loading of the laser crystal.

5.
Opt Lett ; 30(18): 2454-6, 2005 Sep 15.
Article in English | MEDLINE | ID: mdl-16196350

ABSTRACT

Continuous-wave operation of a diode-pumped solid-state Raman laser at 1176 nm is reported. The intracavity Raman laser, based on a Nd:YAG laser crystal and a KGd(WO4)2 Raman crystal, reached threshold for 4 W of diode input power and gave up to 800 mW of output power at an overall conversion efficiency of 4%.

6.
Opt Express ; 12(5): 785-90, 2004 Mar 08.
Article in English | MEDLINE | ID: mdl-19474886

ABSTRACT

We report efficient operation of a KGd(WO(4))(2) Raman laser pumped by a small, 1 W, 532 nm laser module. By changing the output coupler and Raman crystal orientation, more than 8 wavelengths in the yellow-to-red spectral region were generated including 555 nm, 559 nm, 579 nm, 589 nm, 606 nm, 622 nm, 636 nm and 658 nm, ie., the first 4 Stokes orders on the two orthogonal high-gain Raman shifts of KGd(WO(4))(2). We have also demonstrated spectrally pure output (typically >90% pure) for selected Stokes order with output power up to 400 mW. High slope efficiency (up to 68%) and high beam quality (M(2)~1.5) of Stokes output are obtained even at the highest pump power.

7.
Opt Lett ; 28(6): 435-7, 2003 Mar 15.
Article in English | MEDLINE | ID: mdl-12659271

ABSTRACT

As much as 3 W of average power at 1064 nm from a diode-pumped Nd:YAG laser, Q switched at 4 kHz, was used to pump an external-resonator, crystalline Ba(NO3)2 Raman laser generating a maximum of 1.3-W output at the first Stokes wavelength of 1197 nm. The slope efficiency was 63% with respect to the fundamental power incident on the Ba(NO3)2 crystal. A reduction in the beam quality of the Stokes output from M2 approximately 1.4 at lower Stokes powers to M2 approximately 3.4 at higher powers is attributed to thermal loading of the Raman-active crystal.

8.
Opt Lett ; 24(21): 1490-2, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-18079842

ABSTRACT

We report a practical and efficient all-solid-state laser source operating at 578 nm. The source comprises a diode-pumped Nd:YAG laser gain medium producing fundamental output at 1064 nm, an intracavity LiIO (3) Raman-active crystal that generates first-Stokes output at 1155 nm, and an intracavity LiB(3)O(5) frequency-doubling crystal, which frequency doubles the first-Stokes output to 578 nm. Q -switched output with as much as 1.2-W average power has been obtained; conversion efficiencies from the fundamental to the yellow as high as 33% have been obtained.

9.
J Mol Cell Cardiol ; 27(8): 1655-67, 1995 Aug.
Article in English | MEDLINE | ID: mdl-8523428

ABSTRACT

The influence of the adenosine derivative (--)-N6-phenylisopropyladenosine (R-PIA, 1 micron) and 5'N-ethylcarbox-amidoadenosine (NECA, 1 micron) on beta-adrenergic stimulated (isoproterenol, 10 nM) phosphorylation of sarcolemmal (15 kDa protein), sarcoplasmic reticular (phospholamban) and myofibrillar proteins (troponin I, C-protein) was studied in isolated 32P-labeled guinea-pig ventricles. The identification of the 15 kDa protein, phospholamban, troponin I and C-protein was based on their reaction with specific antibodies. Isoproterenol increased contractile parameters (developed tension, rate of tension development, rate of relaxation) and stimulated the phosphorylation state of a 15 kDa protein (now named phospholemman), of phospholamban, troponin I and C-protein (regarded as regulatory proteins). Isoproterenol concomitantly increased myocardial cyclic AMP levels. R-PIA and NECA attenuated the effects of isoproterenol on contractile parameters as well as on the phosphorylation of the regulatory proteins without affecting cyclic AMP levels. The effects of 1 microM R-PIA and 1 microM NECA on the isoproterenol-stimulated phosphorylation of regulatory proteins were blocked by the adenosine receptor antagonist 1.3-dipropyl-8-cyclopentylxanthine (DPCPX, 1 microM). Therefore, it is concluded that adenosine derivatives acting via adenosine receptors can reduce the isoproterenol-stimulated phosphorylation state of the following regulatory proteins: phospholemman, phospholamban, troponin I and C-protein.


Subject(s)
Adenosine/analogs & derivatives , Adrenergic beta-Agonists/pharmacology , Isoproterenol/pharmacology , Myocardium/metabolism , Phenylisopropyladenosine/pharmacology , Phosphoproteins/metabolism , Purinergic P1 Receptor Agonists , Adenosine/pharmacology , Adenosine-5'-(N-ethylcarboxamide) , Animals , Calcium-Binding Proteins/isolation & purification , Calcium-Binding Proteins/metabolism , Carrier Proteins/isolation & purification , Carrier Proteins/metabolism , Female , Guinea Pigs , Heart Ventricles , Male , Myocardial Contraction/drug effects , Phosphoproteins/isolation & purification , Phosphorus Radioisotopes , Phosphorylation , Sarcolemma/metabolism , Sarcoplasmic Reticulum/metabolism , Troponin/isolation & purification , Troponin/metabolism , Troponin I
10.
Biochem Pharmacol ; 49(11): 1583-8, 1995 May 26.
Article in English | MEDLINE | ID: mdl-7786299

ABSTRACT

The effects of inhibitors of protein phosphatase activity on C-protein phosphorylation were studied in preparations from mammalian ventricles. Calyculin A (CyA), an inhibitor of type 1 and 2A protein phosphatases, was studied. CyA concentration- and time-dependency increased the phosphorylation state of C-protein in isolated 32P-labelled guinea pig ventricular cardiomyocytes. C-protein was identified by its reaction with a polyclonal antibody and immunoprecipitation. It is concluded that C-protein in intact cardiomyocytes could be a substrate for type 1 and 2A protein phosphatases.


Subject(s)
Carrier Proteins/metabolism , Myocardium/metabolism , Oxazoles/pharmacology , Phosphoprotein Phosphatases/antagonists & inhibitors , Animals , Cells, Cultured , Guinea Pigs , Heart/drug effects , Heart Ventricles , Marine Toxins , Phosphorylation
11.
J Muscle Res Cell Motil ; 15(6): 633-45, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7706420

ABSTRACT

Cardiac muscle M-band structures in several mammals (guinea pig, rabbit, rat and cow) and also from three teleosts (plaice, carp and roach), have been studied using electron microscopy and image processing. Axial structure seen in negatively stained isolated myofibrils or negatively stained cryo-sections shows the presence of five strong M-bridge lines (M6, M4, M1, M4' and M6') except in the case of the teleost M-bands in which the central M-line (M1) is absent, giving a four-line M-band. The M4 (M4') lines are consistently strong in all muscles, supporting the suggestion that bridges at this position are important for the structural integrity of the A-band myosin filament lattice. Across the vertebrate kingdom, cardiac M-band ultrastructure appears to correlate roughly with heartbeat frequency, just as in skeletal muscles it correlates with contraction speed, reinforcing the suggestion that some M-band components may have a significant physiological role. Apart from rat heart, which is relatively fast and has a conventional five-line M-band with M1 and M4 approximately equal, the rabbit, guinea pig and beef heart M-bands from a new 1 + 4 class; M1 is relatively very much stronger than M4. Transverse sections of the teleost (roach) cardiac A-band show a simple lattice arrangement of myosin filaments, just as teleost skeletal muscles. Almost all other vertebrate striated muscles, including mammalian heart muscles, have a statistical superlattice structure. The high degree of filament lattice order in teleost cardiac muscles indicates their potential usefulness for ultrastructural studies. It is shown that, in four-line M-bands in which the central (M1) M-bridges are missing, interactions at M4 (M4') are sufficient to define the different myosin filament orientations in simple lattice and superlattice A-bands. However the presence of M1 bridges may improve the axial order of the A-band.


Subject(s)
Myocardial Contraction , Myocardium/ultrastructure , Sarcomeres/ultrastructure , Vertebrates/anatomy & histology , Actin Cytoskeleton/ultrastructure , Animals , Cattle , Fishes , Guinea Pigs , Heart Rate , Rabbits , Rats , Species Specificity , Vertebrates/physiology
12.
J Mol Cell Cardiol ; 26(9): 1123-31, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7815456

ABSTRACT

During development of the myocardium the troponin I (TNI) isoform expression is switched from a cAMP-insensitive, slow skeletal muscle TNI to a cAMP-sensitive, cardiac TNI isoform (cTNI). To study the functional consequence of alterations in cTNI expression in the rat heart we investigated the cAMP-controlled cTNI phosphorylation in comparison with alterations of functional properties of isolated cardiac myofibrils during the first postnatal month. cTNI was identified by Western blot analysis followed by a semiquantitative assessment. From the third to the 28th postnatal day the relative concentrations of the cardiac isoform of TNI increased 2.9 +/- 0.3-fold. In the same period the amount of phosphate incorporated into cTNI in the presence of exogenous cAMP-dependent protein kinase (PKA) and 32P[gamma]-ATP was increased 5.8 +/- 0.2-fold (24.2 +/- 3.5 v 140.2 +/- 7.6 pmolP/mg protein loaded onto the gel) whereas the phosphorylation of C-protein was only increased 1.6 +/- 0.2-fold. Ca(2+)-activated isometric tension generation of skinned heart fibres measured in the range of pCa from 6 to 4.5 was not affected by PKA at day 3. However, isometric tension generation of fibres prepared from 28-day-old rats was suppressed by incubation with PKA which was accompanied by a rightward shift in the force/pCa relation. Under these conditions half-maximal tension development was found at pCa 5.38 v 5.52 (p < 0.05) in the absence of PKA. The Ca2+ sensitivity of the contractile apparatus was not affected by PKA-induced phosphorylation of C-protein. These data give direct evidence for the physiological relevance of the onset of cAMP-induced phosphorylation of cTNI for the Ca(2+)-activated tension generation in cardiac myofibrils during postnatal development.


Subject(s)
Myocardial Contraction/physiology , Myocardium/metabolism , Troponin/metabolism , Animals , Animals, Newborn , Calcium/metabolism , Cyclic AMP/metabolism , Cyclic AMP/pharmacology , Cyclic AMP-Dependent Protein Kinases/metabolism , Heart/drug effects , Heart/growth & development , In Vitro Techniques , Phosphorylation , Rats , Rats, Wistar , Troponin I
17.
Biochem J ; 154(2): 327-48, 1976 Feb 15.
Article in English | MEDLINE | ID: mdl-180974

ABSTRACT

The proportion of active (dephosphorylated) pyruvate dehydrogenase in perfused rat heart was decreased by alloxan-diabetes or by perfusion with media containing acetate, n-octanoate or palmitate. The total activity of the dehydrogenase was unchanged. 2. Pyruvate (5 or 25mM) or dichloroacetate (1mM) increased the proportion of active (dephosphorylated) pyruvate dehydrogenase in perfused rat heart, presumably by inhibiting the pyruvate dehydrogenase kinase reaction. Alloxan-diabetes markedly decreased the proportion of active dehydrogenase in hearts perfused with pyruvate or dichloroacetate. 3. The total activity of pyruvate dehydrogenase in mitochondria prepared from rat heart was unchanged by diabetes. Incubation of mitochondria with 2-oxo-glutarate plus malate increased ATP and NADH concentrations and decreased the proportion of active pyruvate dehydrogenase. The decrease in active dehydrogenase was somewhat greater in mitochondria prepared from hearts of diabetic rats than in those from hearts of non-diabetic rats. Pyruvate (0.1-10 mM) or dichloroacetate (4-50 muM) increased the proportion of active dehydrogenase in isolated mitochondria presumably by inhibition of the pyruvate dehydrogenase kinase reaction. They were much less effective in mitochondria from the hearts of diabetic rats than in those of non-diabetic rats. 4. The matrix water space was increased in preparations of mitochondria from hearts of diabetic rats. Dichloroacetate was concentrated in the matrix water of mitochondria of non-diabetic rats (approx. 16-fold at 10 muM); mitochondria from hearts of diabetic rats concentrated dichloroacetate less effectively. 5. The pyruvate dehydrogenase phosphate phosphatase activity of rat hearts and of rat heart mitochondria (approx. 1-2 munit/unit of pyruvate dehydrogenase) was not affected by diabetes. 6. The rate of oxidation of [1-14C]pyruvate by rat heart mitochondria (6.85 nmol/min per mg of protein with 50 muM-pyruvate) was approx. 46% of the Vmax. value of extracted pyruvate dehydrogenase (active form). Palmitoyl-L-carnitine, which increased the ratio of [acetyl-CoA]/[CoA] 16-fold, inhibited oxidation of pyruvate by about 90% without changing the proportion of active pyruvate dehydrogenase.


Subject(s)
Myocardium/enzymology , Pyruvate Dehydrogenase Complex/metabolism , Acetates/pharmacology , Acetyl Coenzyme A/metabolism , Adenosine Triphosphate/metabolism , Animals , Caprylates/pharmacology , Carnitine/analogs & derivatives , Carnitine/pharmacology , Cell Membrane/metabolism , Coenzyme A/metabolism , Diabetes Mellitus, Experimental/metabolism , Fatty Acids/metabolism , Heart/drug effects , In Vitro Techniques , Ketoglutaric Acids/pharmacology , Ketone Bodies/metabolism , Malates/metabolism , Male , Mitochondria, Muscle/enzymology , NAD/metabolism , Oligomycins/metabolism , Palmitates/pharmacology , Perfusion , Phosphates/metabolism , Pyruvates/metabolism , Pyruvates/pharmacology , Rats , Succinates/metabolism
18.
Biochem J ; 154(1): 225-36, 1976 Jan 15.
Article in English | MEDLINE | ID: mdl-6018

ABSTRACT

1. Pyruvate dehydrogenase phosphate phosphatase activity in rat epididymal fat-pads was measured by using pig heart pyruvate dehydrogenase [32P]phosphate. About 80% was found to be extramitochondrial and therefore probably not directly concerned with the regulation of pyruvate dehydrogenase activity. The extramitochondrial activity was sensitive to activation by Ca2+, but perhaps less sensitive than the mitochondrial activity.


Subject(s)
Adipose Tissue/enzymology , Phosphoric Monoester Hydrolases/metabolism , Pyruvate Dehydrogenase (Lipoamide)-Phosphatase/metabolism , Pyruvate Dehydrogenase Complex/metabolism , Adipose Tissue/drug effects , Animals , Calcium/pharmacology , Diabetes Mellitus, Experimental/metabolism , Dietary Fats , Epididymis/enzymology , Glucose/metabolism , In Vitro Techniques , Insulin/pharmacology , Malate Dehydrogenase/metabolism , Male , NADP , Rats , Starvation , Time Factors
19.
Mol Cell Biochem ; 9(1): 27-53, 1975 Oct 31.
Article in English | MEDLINE | ID: mdl-171557

ABSTRACT

In mammalian tissues, two types of regulation of the pyruvate dehydrogenase complex have been described: end product inhibition by acetyl CoA and NADH: and the interconversion of an inactive phosphorylated form and an active nonphosphorylated form by an ATP requiring kinase and a specific phosphatase. This article is largely concerned with the latter type of regulation of the complex in adipose tissue by insulin (and other hormones) and in heart muscle by lipid fuels. Effectors of the two interconverting enzymes include pyruvate and ADP which inhibit the kinase, acetoin which activates the kinase and Ca2+ and Mg2+ which both activate the phosphatase and inhibit the kinase. Evidence is presented that all components of the pyruvate dehydrogenase complex including the phosphatase and kinase are located within the inner mitochondrial membrane. Direct measurements of the matrix concentration of substrates and effectors is not possible by techniques presently available. This is the key problem in the identification of the mechansims involved in the alterations in pyruvate dehydrogenase activity observed in adipose tissue and muscle. A number of indirect approaches have been used and these are reviewed. Most hopeful is the recent finding in this laboratory that in both adipose tissue and heart muscle, differences in activity of pyruvate dehydrogenase in the intact tissue persist during preparation and subsequent incubation of mitochondria.


Subject(s)
Pyruvate Dehydrogenase Complex/metabolism , Acetates/pharmacology , Acetoacetates/pharmacology , Adipose Tissue/drug effects , Adipose Tissue/enzymology , Animals , Butyrates/pharmacology , Calcium/pharmacology , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Edetic Acid/pharmacology , Fructose/pharmacology , Glucose/pharmacology , Glycolysis/drug effects , Insulin/pharmacology , Kinetics , Magnesium/pharmacology , Male , Myocardium/enzymology , Nickel/pharmacology , Palmitic Acids/pharmacology , Phosphotransferases/metabolism , Pyruvate Dehydrogenase (Lipoamide)-Phosphatase/metabolism , Rats , Swine
20.
Biochem J ; 140(2): 225-37, 1974 May.
Article in English | MEDLINE | ID: mdl-4375962

ABSTRACT

The metal-ion requirement of extracted and partially purified pyruvate dehydrogenase phosphate phosphatase from rat epididymal fat-pads was investigated with pig heart pyruvate dehydrogenase [(32)P]phosphate as substrate. The enzyme required Mg(2+) (K(m) 0.5mm) and was activated additionally by Ca(2+) (K(m) 1mum) or Sr(2+) and inhibited by Ni(2+). Isolated fat-cell mitochondria, like liver mitochondria, possess a respiration- or ATP-linked Ca(2+)-uptake system which is inhibited by Ruthenium Red, by uncouplers when linked to respiration, and by oligomycin when linked to ATP. Depletion of fat-cell mitochondria of 75% of their total magnesium content and of 94% of their total calcium content by incubation with the bivalent-metal ionophore A23187 leads to complete loss of pyruvate dehydrogenase phosphate phosphatase activity. Restoration of full activity required addition of both MgCl(2) and CaCl(2). SrCl(2) could replace CaCl(2) (but not MgCl(2)) and NiCl(2) was inhibitory. The metal-ion requirement of the phosphatase within mitochondria was thus equivalent to that of the extracted enzyme. Insulin activation of pyruvate dehydrogenase in rat epididymal fat-pads was not accompanied by any measurable increase in the activity of the phosphatase in extracts of the tissue when either endogenous substrate or (32)P-labelled pig heart substrate was used for assay. The activation of pyruvate dehydrogenase in fat-pads by insulin was inhibited by Ruthenium Red (which may inhibit cell and mitochondrial uptake of Ca(2+)) and by MnCl(2) and NiCl(2) (which may inhibit cell uptake of Ca(2+)). It is concluded that Mg(2+) and Ca(2+) are cofactors for pyruvate dehydrogenase phosphate phosphatase and that an increased mitochondrial uptake of Ca(2+) might contribute to the activation of pyruvate dehydrogenase by insulin.


Subject(s)
Adipose Tissue/enzymology , Calcium/metabolism , Magnesium/metabolism , Phosphoric Monoester Hydrolases/metabolism , Adenosine Triphosphate/metabolism , Animals , Biological Transport , Calcium Radioisotopes , Enzyme Activation , Epididymis/metabolism , Insulin/metabolism , Ketone Oxidoreductases/metabolism , Male , Mitochondria/metabolism , Mitochondria, Liver/metabolism , Myocardium/enzymology , Nickel/pharmacology , Phosphorus Radioisotopes , Pyruvates , Rats , Ruthenium , Strontium/metabolism , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...